On the cover: Immune evasion is a hallmark of cancer. One mechanism of immune evasion involves disrupting the antigen presenting machinery. In this issue of Cell, McGranahan et al. (1259–1271) presented LOHHLA (Loss of Heterozygosity in Human Leukocyte Antigen), a tool to systematically evaluate the prevalence and importance of HLA loss in cancer. By applying this tool to analyze samples from patients with non-small-cell lung cancer, the authors demonstrated that HLA loss is a common subclonal mechanism of immune evasion, subject to strong selection pressures, and associated with an elevated mutation burden and immune activation. The cover image shows a cell surface with HLA class I from both maternal and paternal lineages (in green and pink), presenting brightly colored neoantigen peptides. One of the parental HLA alleles is subject to loss, illustrated by the green HLA class I proteins gradually disappearing from the cell surface. Cover artwork by Jeroen Claus with Phospho Biomedical Animation.
- Explore
Events
Community
Multimedia
Portals
Special Editions
Research Journals
Reviews Journals:
Trends In...
Cell ISSN: 0092-8674
Copyright © 2017 Elsevier Inc. except certain content provided by third parties
